November 15, 2025/
Here is a detailed explanation of the WHO guideline "Recommendations on care for women with diabetes during pregnancy" in English, covering its titles and key details.
ALVigiLance is a dedicated pharmacovigilance platform designed to support the healthcare team in ensuring safer medication use. Our mission is simple yet vital: to provide trusted insights, practical tools, and up-to-date resources that empower healthcare professionals to identify, prevent, and manage adverse drug reactions (ADRs).
Simplified, practical guides on drug safety and monitoring.
Real-world examples to strengthen your clinical decision-making.
Summaries of global drug warnings and regulatory actions.
Strategies for adverse event reporting, risk management, and patient counseling.
To create a proactive community of healthcare providers who champion medication safety and improve patient outcomes through shared knowledge and vigilance.
Medication safety is everyone’s responsibility. Explore, learn, and engage with ALVigiLance — because together, we can reduce risks and save lives.
Here is a detailed explanation of the WHO guideline "Recommendations on care for women with diabetes during pregnancy" in English, covering its titles and key details.
Here is a detailed, comprehensive explanation of Root Cause Analysis (RCA), its application in pharmacovigilance, and its critical role in advancing drug safety.
In the high-stakes environment of patient care, we administer powerful medications with the intent to heal, to cure, and to save lives. Yet, for certain critical...
